Attila Hamar

1.3k total citations · 1 hit paper
19 papers, 272 citations indexed

About

Attila Hamar is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, Attila Hamar has authored 19 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Attila Hamar's work include Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (8 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Attila Hamar is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (8 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Attila Hamar collaborates with scholars based in Hungary, United States and Netherlands. Attila Hamar's co-authors include Zoltán Szekanecz, Paco M J Welsing, Melinda Kedves, Désirée van der Heijde, Jacob M. van Laar, Nadia M T Roodenrijs, György Nagy, Gabriella Szűcs, Edit Végh and Szilvia Szamosi and has published in prestigious journals such as Annals of the Rheumatic Diseases, Nature Reviews Rheumatology and Lara D. Veeken.

In The Last Decade

Attila Hamar

17 papers receiving 266 citations

Hit Papers

Efficacy and safety of JAK inhibitors in rheumatoid arthr... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician
    2024 58 citations Zoltán Szekanecz, Maya H Buch et al. Nature Reviews Rheumatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Attila Hamar Hungary 9 178 70 48 44 40 19 272
Melinda Kedves Hungary 5 172 1.0× 85 1.2× 59 1.2× 36 0.8× 32 0.8× 6 238
Kaoru Takase-Minegishi Japan 7 178 1.0× 57 0.8× 67 1.4× 21 0.5× 31 0.8× 11 287
Lykke Midtbøll Ørnbjerg Denmark 11 177 1.0× 80 1.1× 45 0.9× 20 0.5× 28 0.7× 26 275
Mahmood M. T. M. Ally South Africa 9 214 1.2× 55 0.8× 48 1.0× 17 0.4× 45 1.1× 23 316
Yeong-Wook Song South Korea 8 207 1.2× 89 1.3× 69 1.4× 25 0.6× 80 2.0× 13 382
Risto Perich-Campos Peru 10 248 1.4× 139 2.0× 26 0.5× 48 1.1× 24 0.6× 34 305
Sairah Khan United States 7 54 0.3× 108 1.5× 33 0.7× 32 0.7× 28 0.7× 17 277
S. Cohen United States 5 148 0.8× 50 0.7× 87 1.8× 50 1.1× 25 0.6× 8 250
Yukiko Takakuwa Japan 9 104 0.6× 68 1.0× 25 0.5× 20 0.5× 34 0.8× 35 219
Mikhail Volkov Netherlands 7 128 0.7× 84 1.2× 22 0.5× 17 0.4× 50 1.3× 17 239

Countries citing papers authored by Attila Hamar

Since Specialization
Citations

This map shows the geographic impact of Attila Hamar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Attila Hamar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Attila Hamar more than expected).

Fields of papers citing papers by Attila Hamar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Attila Hamar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Attila Hamar. The network helps show where Attila Hamar may publish in the future.

Co-authorship network of co-authors of Attila Hamar

This figure shows the co-authorship network connecting the top 25 collaborators of Attila Hamar. A scholar is included among the top collaborators of Attila Hamar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Attila Hamar. Attila Hamar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Szekanecz, Zoltán, Maya H Buch, Christina Charles‐Schoeman, et al.. (2024). Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature Reviews Rheumatology. 20(2). 101–115. 58 indexed citations breakdown →
2.
Szekanecz, Zoltán, Maya H Buch, Christina Charles‐Schoeman, et al.. (2024). Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature Reviews Rheumatology. 20(3). 196–196.
3.
Kerekes, György, Attila Hamar, Gábor Tajti, et al.. (2023). Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis. Lara D. Veeken. 62(SI3). SI304–SI312. 6 indexed citations
4.
Horváth, Ágnes, Edit Végh, Boglárka Soós, et al.. (2023). Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis. Frontiers in Medicine. 10. 1226760–1226760.
5.
Soós, Boglárka, Attila Hamar, Edit Végh, et al.. (2022). Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach. Frontiers in Medicine. 9. 1011734–1011734. 11 indexed citations
6.
Soós, Boglárka, Miklós Fagyas, Ágnes Horváth, et al.. (2022). Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients. Frontiers in Medicine. 8. 785744–785744. 6 indexed citations
7.
Roodenrijs, Nadia M T, Melinda Kedves, Attila Hamar, et al.. (2021). Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. RMD Open. 7(1). e001511–e001511. 23 indexed citations
8.
9.
Végh, Edit, Ágnes Horváth, Attila Hamar, et al.. (2021). Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology. Biomolecules. 11(10). 1535–1535. 10 indexed citations
10.
11.
Soós, Boglárka, Attila Hamar, É. Végh, et al.. (2021). POS0383 EFFECTS OF TOFACITINIB THERAPY ON ARGININE AND METHIONINE METABOLITES IN ASSOCIATION WITH VASCULAR PATHOPHYSIOLOGY IN RHEUMATOID ARTHRITIS: A METABOLOMIC APPROACH. Annals of the Rheumatic Diseases. 80. 421–422. 3 indexed citations
12.
13.
Póliska, Szilárd, Tímea Besenyei, Edit Végh, et al.. (2019). Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis. Arthritis Research & Therapy. 21(1). 94–94. 9 indexed citations
14.
Végh, Edit, György Kerekes, Attila Hamar, et al.. (2019). Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis. Rheumatology International. 40(3). 427–436. 29 indexed citations
15.
Sarzi‐Puttini, Piercarlo, Daniela Marotto, Roberto Caporali, et al.. (2019). Biosimilars vs originators: Are they the same?. Autoimmunity Reviews. 18(12). 102404–102404. 8 indexed citations
16.
Horváth, Ágnes, Edit Végh, Attila Hamar, et al.. (2019). Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients. Arthritis Research & Therapy. 21(1). 274–274. 15 indexed citations
17.
Balogh, Emese, Attila Hamar, Edit Végh, et al.. (2018). Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis. Clinical Immunology. 199. 47–51. 7 indexed citations
18.
Szekanecz, Zoltán, Zoltán Tóth, Attila Hamar, & Levente Lánczi. (2017). Miért mennek/mentek külföldre a debreceni orvosok? Egy felmérés eredményei. Orvosi Hetilap. 158(37). 1458–1468. 1 indexed citations
19.
Végh, É., Ágnes Horváth, Attila Hamar, et al.. (2017). THU0694 Effects of ANTI-TNF therapy on solubile urokinase plasminogen activator receptor (SUPAR) levels in arthritis. Annals of the Rheumatic Diseases. 76. 469–470. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melinda Kedves Breakdown of academic impact, for papers by Kaoru Takase-Minegishi Breakdown of academic impact, for papers by Lykke Midtbøll Ørnbjerg Breakdown of academic impact, for papers by Mahmood M. T. M. Ally Breakdown of academic impact, for papers by Yeong-Wook Song Breakdown of academic impact, for papers by Risto Perich-Campos Breakdown of academic impact, for papers by Sairah Khan Breakdown of academic impact, for papers by S. Cohen Breakdown of academic impact, for papers by Yukiko Takakuwa Breakdown of academic impact, for papers by Mikhail Volkov
Rankless by CCL
2026